Y10S 930/14
Lymphokine
Official title: Lymphokine; related peptides
Y10S930/14 (Lymphokine) appears on 368 US grants and 75 published applications in this corpus.
Search patents in Y10S- Granted patents
- 368
- Published applications
- 75
- Assignees
- 143
- Inventors
- 601
- Latest grant
- 19 Apr 2016
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 1 | 0 |
| 1982 | 3 | 0 |
| 1983 | 4 | 0 |
| 1984 | 6 | 0 |
| 1985 | 5 | 0 |
| 1986 | 8 | 0 |
| 1987 | 23 | 0 |
| 1988 | 29 | 0 |
| 1989 | 28 | 0 |
| 1990 | 6 | 0 |
| 1991 | 2 | 0 |
| 1992 | 9 | 0 |
| 1993 | 11 | 0 |
| 1994 | 19 | 0 |
| 1995 | 6 | 0 |
| 1996 | 16 | 0 |
| 1997 | 33 | 0 |
| 1998 | 24 | 0 |
| 1999 | 30 | 0 |
| 2000 | 22 | 0 |
| 2001 | 15 | 1 |
| 2002 | 14 | 8 |
| 2003 | 7 | 17 |
| 2004 | 10 | 9 |
| 2005 | 5 | 5 |
| 2006 | 3 | 4 |
| 2007 | 3 | 6 |
| 2008 | 4 | 3 |
| 2009 | 3 | 7 |
| 2010 | 4 | 4 |
| 2011 | 7 | 7 |
| 2012 | 4 | 1 |
| 2013 | 1 | 1 |
| 2014 | 1 | 0 |
| 2015 | 1 | 1 |
| 2016 | 1 | 1 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Polymer conjugates of interferon beta-1A and uses19 Apr 2016US 9,314,534 B2Biogen MA Inc.
- Methods for treating myocardial infarction comprising administering an IL-6 inhibitor3 Feb 2015US 8,945,558 B2Chugai Seiyaku Kabushiki Kaisha
- Method for promoting muscle repair comprising administering G-CSF at the site of injury23 Sep 2014US 8,841,250 B2
- Methods for inhibiting lymphotoxin-β receptor signaling in TH1 cell-associated disorders4 Jun 2013US 8,455,445 B2Biogen Idec MA Inc.
- Nucleic acids encoding modulators of body weight8 May 2012US 8,173,793 B2The Rockefeller University
- Polymer conjugates of interferon beta-1a and uses1 Sep 2016US 2016/0250340 A1Biogen MA Inc.
- Polymer conjugates of interferon beta-1a and uses8 Jan 2015US 2015/0011732 A1Biogen MA Inc.
- Muscle repair promoter14 Nov 2013US 2013/0302271 A1
- Muscle repair promoter10 May 2012US 2012/0114594 A1Keiichi Fukuda
- Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling13 Oct 2011US 2011/0250200 A1Biogen Idec MA Inc.
Most cited
By later US patents
- Interleukin-2 muteins and polymer conjugation thereof444US 5,206,344 ACetus Oncology Corporation · 1993
- Human recombinant interleukin-2 muteins297US 4,518,584 ACetus Corporation · 1985
- Covalently linked polypeptide cell modulators269US 4,935,233 AG. D. Searle & Co. · 1990
- Human recombinant cysteine depleted interferon-.beta. muteins253US 4,588,585 ACetus Corporation · 1986
- Conjugation of polymer to colony stimulating factor-1244US 4,847,325 ACetus Corporation · 1989